ADPT new logo.jpg
Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline
April 12, 2023 07:30 ET | Adaptive Biotechnologies
SEATTLE, April 12, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
Vantage Market Research.png
Veterinary Diagnostics Market Size & Share to Surpass $ 4663.51 Million by 2030 | Vantage Market Research
April 10, 2023 05:00 ET | Vantage Market Research
WASHINGTON, April 10, 2023 (GLOBE NEWSWIRE) -- Global Veterinary Diagnostics Market valued at USD 2375.10 Million in 2022 and is projected to reach a value of USD 4663.51 Million by 2030 at a CAGR...
IMF_logo_RGB.png
The International Myeloma Foundation Announces the Annual Miles for Myeloma 5K Run/Walk: 15 Years of Making a Difference in the Myeloma Community
April 03, 2023 08:45 ET | International Myeloma Foundation
PHILADELPHIA, April 03, 2023 (GLOBE NEWSWIRE) -- The Annual Miles for Myeloma Hybrid 5K Run/Walk will once again “Redefine Being Together” on Saturday, April 29, virtually and in-person at FDR Park...
Aptose Biosciences Inc. logo
Aptose Reports Results for the Fourth Quarter and Full Year 2022
March 23, 2023 16:44 ET | Aptose Biosciences, Inc.
─ APTIVATE Expansion Trial of Tuspetinib as Single Agent in Relapsed/Refractory AML Patients is Up and Running; Initiated Enrollment of Combination Treatment Arm with Venetoclax ─ ─ RAS Mutated AML...
IMF_logo_RGB.png
International Myeloma Foundation (IMF) Launches #MYelomaSTORY Campaign for Myeloma Action Month in March 2023
February 23, 2023 08:45 ET | International Myeloma Foundation
STUDIO CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- With the International Myeloma Foundation (IMF) at the forefront, Myeloma Action Month is held every year for the whole month of March to...
TIP_link_300x300.jpg
Home Infusion Therapy Market Revenue to Cross $35.69 Billion, Globally, by 2028 – Exclusive Report by The Insight Partners
February 21, 2023 08:32 ET | The Insight Partners
New York, Feb. 21, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Home Infusion Therapy Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...
TIP_link_300x300.jpg
Apheresis Equipment Market Share to Outstrip $3.85 Billion, Globally, by 2028 with 8% CAGR – Growth Report by The Insight Partners
February 09, 2023 09:47 ET | The Insight Partners
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Apheresis Equipment Market Size, Share, Revenue, Sales and Global Forecast to 2028 - Global Analysis by Product...
IMF_logo_RGB.png
International Myeloma Foundation (IMF) Returns to In-Person Patient and Family Seminars in 2023, Announces Boca Raton Event
February 02, 2023 08:45 ET | International Myeloma Foundation
BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that this year’s first Patient and Family Seminar is taking place in-person and...
Color Logo.png
Veterinary Hematology Analyzers Market is expected to grow from USD 850 million in 2022 to USD 1515.9 million by 2030 : GreyViews
January 27, 2023 16:00 ET | GreyViews
Pune India, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
New Logo.png
Provectus Biopharmaceuticals Releases 2023 Stockholder Letter
January 09, 2023 08:00 ET | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that it had issued a beginning-of-the-year letter for 2023 to the Company’s stockholders, which may be found...